Loading organizations...
§ Private Profile · Sunnyvale, CA, USA
Medical device company developing FDA-approved endoscopic treatment systems for Barrett's esophagus, focused on gastroenterology.
Sunnyvale, California-based BARRX Medical develops FDA-approved endoscopic radiofrequency ablation systems designed to treat Barrett's esophagus and prevent the progression of esophageal cancer. Operating primarily within the gastroenterology sector, the medical device manufacturer raised $49.6 million in total venture capital funding to commercialize its proprietary HALO system. The company's minimally invasive technology achieved an estimated 95 percent market share, generating recurring revenue through capital equipment sales and disposable ablation catheters utilized in over 90,000 patient procedures across more than 400 global hospitals and medical centers. Led by former Chief Executive Officer Greg Barrett, the enterprise was acquired by Covidien for $325 million in 2012 before ultimately becoming integrated into the broader product portfolio of Medtronic. BARRX Medical was originally founded in 2000 by Dr. Robert Ganz and Roger Stern with incubation support from Stellartech Research Corporation.
BARRX Medical has raised $15.0M across 1 funding round.
BARRX Medical has raised $15.0M in total across 1 funding round.
BARRX Medical has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series D in July 2010.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 14, 2010 | $15M Series D | Bijan Salehizadeh | Alloy Ventures, Delphi Ventures, Frazier Healthcare Partners, Greenspring Associates, Sutter Hill Ventures | Announced |
BARRX Medical has raised $15.0M in total across 1 funding round.
BARRX Medical's investors include Bijan Salehizadeh, Alloy Ventures, Delphi Ventures, Frazier Healthcare Partners, Greenspring Associates, Sutter Hill Ventures.